Table 2 Radiotherapy characteristics
RT characteristics | Median (IQR) |
|---|---|
Time interval RP–RT (months) | 36.13 (15.0-68.3) |
WPRT (n, %) | |
Yes | 69 (68.3) |
No | 32 (31.6) |
Boost to lymph-nodes (n, %) | |
Yes | 7 (6.9%) |
No | 94 (93.1%) |
Dose (Gy) | |
Recurrent nodule | 73.5 |
Prostatic fossa | 69 (66–69) |
Seminal vesicle bed | 66 (60–66) |
WPRT | 54 |
Boost to lymph-nodes | 66 (60–66) |
Number of fractions | 30 |
Total PTV (cm3) | 1393.8 (243.9-1539.5) |
CTV T (prostate/vesicles) (cm3) | 50.8 (33.1–66) |
CTV WPRT (cm3) | 408.7 (0-495.9) |
PTV WPRT (cm3) | 1211.8 (0-1355.7) |
Dosimetric characteristics of WPRT CTV | |
Dmean (Gy) | 5445 (0-5515.5) |
Dmax (Gy) | 5777 (0-6027.6) |
Dmin (Gy) | 5049 (0-5147) |